Table A4.
Response | No. | % |
---|---|---|
Total responders | 39 | 66 |
DOR longer after lenalidomide and rituximab | 26 | 44 |
DOR shorter after lenalidomide and rituximab | 7 | 12 |
Ongoing response | 6 | 10 |
Abbreviation: DOR, duration of response.
Response | No. | % |
---|---|---|
Total responders | 39 | 66 |
DOR longer after lenalidomide and rituximab | 26 | 44 |
DOR shorter after lenalidomide and rituximab | 7 | 12 |
Ongoing response | 6 | 10 |
Abbreviation: DOR, duration of response.